REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

Part of paid clinical trials in Flint, Michigan.

Sponsor
Medtronic Neurovascular Clinical Affairs
Study ID
NCT07599904
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Mechanical Thrombectomy — DEVICE
    Index stroke procedure and follow-up visits up to 90 days post index procedure

Study Details

Post-Market Registry

Key Dates

First listed
May 20, 2026
Start date
Jul 31, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2031
Completion
Jul 31, 2031

Study Design

Enrollment
1,500 participants (estimated)

Primary Outcome Measure

Evaluate device safety [ Time Frame: From Day 0 to 90 days post-procedure ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
McLaren Flint HospitalFlintMichigan48532
Mahmoud Rayes, MD
[email protected]
810-342-4071
Buffalo General Medical CenterBuffaloNew York14203
Jason Davies, MD
[email protected]
716-218-1000

Find similar trials in Flint, MI

By condition
Stroke
By specialty
NeurologyBrain disorders
By research site
McLaren Flint Hospital· Flint, MIBuffalo General Medical Center· Buffalo, NY

Related Studies